Q2 2021 Vistin Pharma ASA Earnings Call Transcript
Thank you all for standing by, and welcome to the quarterly report Q2 2021. (Operator Instructions) Please be advised that today's call is being recorded. I would now like to hand the call over to your CEO, Kjell-Erik Nordby. Thank you.
Thank you. Welcome to the presentation of the second quarter and the first half 2021 results in Vistin Pharma. The presentation will be held by myself and the CFO in Vistin Pharma, Alexander Karlsen.
We start with a summary of the quarter. We had a record-high sales volume in the second quarter of 2021. However, the revenue was negatively affected by a significantly stronger NOK versus euro compared to the similar quarter last year. This resulted in a revenue of NOK 67 million versus NOK 73 million in the same quarter last year, an 8% decrease.
First -- the revenue for the first half of 2021 ended at NOK 138 million compared to NOK 134 million last year, which is a 2% growth.
EBITDA for the quarter ended at NOK 15.6 million versus NOK 20.9
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
